Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New non-invasive techniques can improve diagnosis and treatment of scalp and hair diseases.

Aesthetic medicine is rapidly advancing with new technologies for safer, personalized, and less invasive treatments.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Minoxidil can slow hair loss and promote regrowth but won't fully restore hair.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Children with scalp fungal infections need proper diagnosis and treatment, usually with antifungal medications, and newer drugs may offer quicker recovery.

The document concludes that proper diagnosis and treatment of common scalp disorders are important for both physical and psychological health.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Topical treatment is recommended for Folliculitis decalvans in pregnant women.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Most pediatric inpatients needed dermatology consultations for unspecified rashes and drug reactions, with varied treatments.

Vitamin D is crucial for skin health and managing skin diseases.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.